Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > New patent

<< Previous

Bullboard Posts

Next >>

Comment by hcdtradingon Aug 31, 2022 1:25pm

133 Views

Post# 34932957

RE:RE:RE:RE:RE:RE:New patent

Bio give it a break man, it could be very lucrative huh? Is pumping this stock regardless of how terrible it is your full time job? 24/7 365 days a year we can depend on bio to pump SBM.

The company sucks! you know that and every investor knows it. enough already.

What do you rate Howard as CEO again? you keep avoiding this because you work for SBM and cant say what you rate him as ceo.

<< Previous

Bullboard Posts

Next >>

Bombardier completes partial redemption of US$200 million